Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $7.96 Million - $13.8 Million
440,283 Added 11.82%
4,163,824 $93.1 Million
Q2 2022

Aug 15, 2022

BUY
$13.31 - $34.88 $19.1 Million - $50 Million
1,432,100 Added 62.5%
3,723,541 $62.4 Million
Q1 2022

May 16, 2022

BUY
$20.26 - $32.36 $10.4 Million - $16.6 Million
512,357 Added 28.8%
2,291,441 $68.6 Million
Q4 2021

Feb 14, 2022

BUY
$26.0 - $37.03 $10.2 Million - $14.6 Million
393,808 Added 28.43%
1,779,084 $54.6 Million
Q3 2021

Nov 15, 2021

SELL
$29.75 - $37.99 $92.3 Million - $118 Million
-3,102,500 Reduced 69.13%
1,385,276 $43.7 Million
Q2 2021

Aug 16, 2021

BUY
$27.5 - $38.19 $29.1 Million - $40.4 Million
1,058,413 Added 30.86%
4,487,776 $164 Million
Q1 2021

May 17, 2021

BUY
$32.52 - $61.53 $7.44 Million - $14.1 Million
228,714 Added 7.15%
3,429,363 $119 Million
Q3 2020

Nov 16, 2020

BUY
$32.81 - $45.1 $105 Million - $144 Million
3,200,649 New
3,200,649 $136 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $780M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.